278 related articles for article (PubMed ID: 29738849)
1. 5-HT
Fukumoto K; Iijima M; Funakoshi T; Chaki S
Neuropharmacology; 2018 Jul; 137():96-103. PubMed ID: 29738849
[TBL] [Abstract][Full Text] [Related]
2. The Antidepressant Effects of an mGlu2/3 Receptor Antagonist and Ketamine Require AMPA Receptor Stimulation in the mPFC and Subsequent Activation of the 5-HT Neurons in the DRN.
Fukumoto K; Iijima M; Chaki S
Neuropsychopharmacology; 2016 Mar; 41(4):1046-56. PubMed ID: 26245499
[TBL] [Abstract][Full Text] [Related]
3. Role of 5-HT1A Receptor Stimulation in the Medial Prefrontal Cortex in the Sustained Antidepressant Effects of Ketamine.
Fukumoto K; Iijima M; Funakoshi T; Chaki S
Int J Neuropsychopharmacol; 2018 Apr; 21(4):371-381. PubMed ID: 29309585
[TBL] [Abstract][Full Text] [Related]
4. Serotonin-1A receptor stimulation mediates effects of a metabotropic glutamate 2/3 receptor antagonist, 2S-2-amino-2-(1S,2S-2-carboxycycloprop-1-yl)-3-(xanth-9-yl)propanoic acid (LY341495), and an N-methyl-D-aspartate receptor antagonist, ketamine, in the novelty-suppressed feeding test.
Fukumoto K; Iijima M; Chaki S
Psychopharmacology (Berl); 2014 Jun; 231(11):2291-8. PubMed ID: 24402133
[TBL] [Abstract][Full Text] [Related]
5. The Rapidly Acting Antidepressant Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Rapidly Engage Dopaminergic Mood Circuits.
Witkin JM; Monn JA; Schoepp DD; Li X; Overshiner C; Mitchell SN; Carter G; Johnson B; Rasmussen K; Rorick-Kehn LM
J Pharmacol Exp Ther; 2016 Jul; 358(1):71-82. PubMed ID: 27189960
[TBL] [Abstract][Full Text] [Related]
6. Cortical and raphe GABA
Pham TH; Defaix C; Nguyen TML; Mendez-David I; Tritschler L; David DJ; Gardier AM
Pharmacol Biochem Behav; 2020 May; 192():172913. PubMed ID: 32201299
[TBL] [Abstract][Full Text] [Related]
7. Requirement of AMPA receptor stimulation for the sustained antidepressant activity of ketamine and LY341495 during the forced swim test in rats.
Koike H; Chaki S
Behav Brain Res; 2014 Sep; 271():111-5. PubMed ID: 24909673
[TBL] [Abstract][Full Text] [Related]
8. Role of BDNF/TrkB signaling in antidepressant-like effects of a group II metabotropic glutamate receptor antagonist in animal models of depression.
Koike H; Fukumoto K; Iijima M; Chaki S
Behav Brain Res; 2013 Feb; 238():48-52. PubMed ID: 23098797
[TBL] [Abstract][Full Text] [Related]
9. Serotonergic mechanisms involved in antidepressant-like responses evoked by GLT-1 blockade in rat infralimbic cortex.
Gasull-Camós J; Martínez-Torres S; Tarrés-Gatius M; Ozaita A; Artigas F; Castañé A
Neuropharmacology; 2018 Sep; 139():41-51. PubMed ID: 29940206
[TBL] [Abstract][Full Text] [Related]
10. Ketamine treatment involves medial prefrontal cortex serotonin to induce a rapid antidepressant-like activity in BALB/cJ mice.
Pham TH; Mendez-David I; Defaix C; Guiard BP; Tritschler L; David DJ; Gardier AM
Neuropharmacology; 2017 Jan; 112(Pt A):198-209. PubMed ID: 27211253
[TBL] [Abstract][Full Text] [Related]
11. The peptidic antidepressant spadin interacts with prefrontal 5-HT(4) and mGluR(2) receptors in the control of serotonergic function.
Moha ou Maati H; Bourcier-Lucas C; Veyssiere J; Kanzari A; Heurteaux C; Borsotto M; Haddjeri N; Lucas G
Brain Struct Funct; 2016 Jan; 221(1):21-37. PubMed ID: 25233810
[TBL] [Abstract][Full Text] [Related]
12. AMPA receptor-mTORC1 signaling activation is required for neuroplastic effects of LY341495 in rat hippocampal neurons.
Seo MK; Hien LT; Park MK; Choi AJ; Seog DH; Kim SH; Park SW; Lee JG
Sci Rep; 2020 Jan; 10(1):993. PubMed ID: 31969673
[TBL] [Abstract][Full Text] [Related]
13. Medial PFC AMPA receptor and BDNF signaling are required for the rapid and sustained antidepressant-like effects of 5-HT
Fukumoto K; Fogaça MV; Liu RJ; Duman CH; Li XY; Chaki S; Duman RS
Neuropsychopharmacology; 2020 Sep; 45(10):1725-1734. PubMed ID: 32396921
[TBL] [Abstract][Full Text] [Related]
14. The group II mGlu receptor antagonist LY341495 induces a rapid antidepressant-like effect and enhances the effect of ketamine in the chronic unpredictable mild stress model of depression in C57BL/6J mice.
Pałucha-Poniewiera A; Podkowa K; Rafało-Ulińska A
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jul; 109():110239. PubMed ID: 33400944
[TBL] [Abstract][Full Text] [Related]
15. Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists.
Koike H; Iijima M; Chaki S
Neuropharmacology; 2011 Dec; 61(8):1419-23. PubMed ID: 21903115
[TBL] [Abstract][Full Text] [Related]
16. Metabotropic glutamate 2/3 receptor antagonists improve behavioral and prefrontal dopaminergic alterations in the chronic corticosterone-induced depression model in mice.
Ago Y; Yano K; Araki R; Hiramatsu N; Kita Y; Kawasaki T; Onoe H; Chaki S; Nakazato A; Hashimoto H; Baba A; Takuma K; Matsuda T
Neuropharmacology; 2013 Feb; 65():29-38. PubMed ID: 23022081
[TBL] [Abstract][Full Text] [Related]
17. Group II mGlu receptor antagonist LY341495 enhances the antidepressant-like effects of ketamine in the forced swim test in rats.
Podkowa K; Pochwat B; Brański P; Pilc A; Pałucha-Poniewiera A
Psychopharmacology (Berl); 2016 Aug; 233(15-16):2901-14. PubMed ID: 27286960
[TBL] [Abstract][Full Text] [Related]
18. Role of AMPA receptor stimulation and TrkB signaling in the antidepressant-like effect of ketamine co-administered with a group II mGlu receptor antagonist, LY341495, in the forced swim test in rats.
Pałucha-Poniewiera A; Podkowa K; Pilc A
Behav Pharmacol; 2019 Sep; 30(6):471-477. PubMed ID: 30724804
[TBL] [Abstract][Full Text] [Related]
19. Activation of the mTOR signaling pathway in the antidepressant-like activity of the mGlu5 antagonist MTEP and the mGlu7 agonist AMN082 in the FST in rats.
Pałucha-Poniewiera A; Szewczyk B; Pilc A
Neuropharmacology; 2014 Jul; 82():59-68. PubMed ID: 24631968
[TBL] [Abstract][Full Text] [Related]
20. Intranasal Administration of Resolvin E1 Produces Antidepressant-Like Effects via BDNF/VEGF-mTORC1 Signaling in the Medial Prefrontal Cortex.
Deyama S; Aoki S; Sugie R; Fukuda H; Shuto S; Minami M; Kaneda K
Neurotherapeutics; 2023 Mar; 20(2):484-501. PubMed ID: 36622634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
